Pyrrole compounds
PL3947349T3Active Publication Date: 2026-07-27ALIGOS THERAPEUTICS INC +1
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- PL2020784496T
- Authority / Receiving Office
- PL · PL
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2020-04-01
- Filing Date
- 2020-04-01
- Publication Date
- 2026-07-27
- Estimated Expiration
- 2040-04-01
AI Technical Summary
Technical Problem
Current treatments for hepatitis B and hepatitis D infections are inadequate, as they do not cure the infections but only suppress virus replication, and hepatitis D has a high fatality rate with no cure or vaccine available.
Method used
Development of pyrrole compounds or their pharmaceutically acceptable salts for use in treating hepatitis B and D infections, including methods of administration and inhibition of viral replication.
Benefits of technology
The pyrrole compounds effectively inhibit hepatitis B and D virus replication, offering a potential cure for these infections and reducing the severity and fatality associated with hepatitis D.
✦ Generated by Eureka AI based on patent content.
Need to check novelty before this filing date? Find Prior Art
No text content released.